Alan Montgomery
Directeur/Membre du Conseil chez XENCOR, INC.
Fortune : - $ au 30/04/2024
Provenance du réseau au premier degré de Alan Montgomery
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 47 | |
29
| Public Company | Biotechnology | 29 |
| Subsidiary | Pharmaceuticals: Major | 25 | |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
17
| Extinct | Pharmaceuticals: Major | 17 |
W Fund Management LLC
 W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington.
16
| Private Company | Investment Managers | 16 |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA.
11
| Extinct | Pharmaceuticals: Major | 11 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million.
7
| Subsidiary | Biotechnology | 7 |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Vicis LLC
 Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA.
5
| Holding Company | Recreational Products | 5 |
| Public Company | Pharmaceuticals: Major | 4 | |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Alan Montgomery via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | President Director/Board Member Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Masters Business Admin | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Genesis Research & Development Corp. Ltd.
 Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Madrona Venture Group LLC
 Madrona Venture Group LLC Investment ManagersFinance Madrona Venture Group LLC (Madrona Venture Group) is a venture capital firm founded in 1995 by Tom A. Alberg, Paul B. Goodrich and Jerry Grinstein. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Chief Operating Officer Private Equity Investor | |
| Emory University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor Private Equity Investor Private Equity Investor | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Arizona | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor Private Equity Investor Private Equity Analyst | |
| ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| University of California, Davis | College/University | Doctorate Degree Doctorate Degree | |
| Oregon Health & Science University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Kenyon College | College/University | Director/Board Member Undergraduate Degree | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Founder | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| NANOSTRING TECHNOLOGIES, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| University of California | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 45 |
| Royaume-Uni | 3 |
| Canada | 3 |
| Nouvelle-Zélande | 2 |
Sectorielle
| Consumer Services | 21 |
| Health Technology | 18 |
| Finance | 7 |
| Commercial Services | 6 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 535 |
| Corporate Officer/Principal | 223 |
| Independent Dir/Board Member | 145 |
| Chairman | 90 |
| Undergraduate Degree | 88 |
Relations les plus connectées
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Chad Waite | 39 |
| Jonathan Fleming | 36 |
| Robin Washington | 34 |
| Heather Elizabeth Preston | 34 |
| Deepa Pakianathan | 32 |
| Patrick Ennis | 30 |
| Peter Bisgaard | 28 |
| Bruce Carter | 25 |
| Douglas Williams | 25 |
| Per Wold-Olsen | 24 |
| Robert F. Baltera | 23 |
| Stephen M. Dow | 20 |
| Wendy Yarno | 19 |
| Richard Whitley | 18 |
- Bourse
- Insiders
- Alan Montgomery
- Connexions Sociétés